Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/23–25/05/28 | 25/05/28 | 1,386,060 sh3 trades | $6.58avg. | $9,126,684.03 | −84.0% | |
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/23–25/05/28 | 25/05/28 | 1,386,060 sh3 trades | $6.58avg. | $9,126,684.03 | −84.0% | |
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/23–25/05/28 | 25/05/28 | 1,386,060 sh3 trades | $6.58avg. | $9,126,684.03 | −84.0% | |
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/23–25/05/28 | 25/05/28 | 1,386,060 sh3 trades | $6.58avg. | $9,126,684.03 | −84.0% | |
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/23–25/05/28 | 25/05/28 | 1,386,060 sh3 trades | $6.58avg. | $9,126,684.03 | −84.0% | |
22NW Fund10% Owner | Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/13 | 25/05/16 | 12,334 sh | $7.00 | $86,338 | −0.7% |
22NW10% Owner | Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/13 | 25/05/16 | 12,334 sh | $7.00 | $86,338 | −0.7% |
Aron R. English10% Owner | Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/13 | 25/05/16 | 12,334 sh | $7.00 | $86,338 | −0.7% |
22NW Fund GP10% Owner | Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/13 | 25/05/16 | 12,334 sh | $7.00 | $86,338 | −0.7% |
22NW GP10% Owner | Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/13 | 25/05/16 | 12,334 sh | $7.00 | $86,338 | −0.7% |
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/08–25/05/12 | 25/05/12 | 51,496 sh3 trades | $7.03avg. | $361,842.94 | −3.0% | |
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/08–25/05/12 | 25/05/12 | 51,496 sh3 trades | $7.03avg. | $361,842.94 | −3.0% | |
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/08–25/05/12 | 25/05/12 | 51,496 sh3 trades | $7.03avg. | $361,842.94 | −3.0% | |
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/08–25/05/12 | 25/05/12 | 51,496 sh3 trades | $7.03avg. | $361,842.94 | −3.0% | |
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/08–25/05/12 | 25/05/12 | 51,496 sh3 trades | $7.03avg. | $361,842.94 | −3.0% | |
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/05–25/05/07 | 25/05/07 | 41,091 sh3 trades | $7.05avg. | $289,793.96 | −2.3% | |
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/05–25/05/07 | 25/05/07 | 41,091 sh3 trades | $7.05avg. | $289,793.96 | −2.3% | |
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/05–25/05/07 | 25/05/07 | 41,091 sh3 trades | $7.05avg. | $289,793.96 | −2.3% | |
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/05–25/05/07 | 25/05/07 | 41,091 sh3 trades | $7.05avg. | $289,793.96 | −2.3% | |
Lifecore Biomedical, Inc. \de\LFCR | Open-market sale | 25/05/05–25/05/07 | 25/05/07 | 41,091 sh3 trades | $7.05avg. | $289,793.96 | −2.3% |